XTalks

AUGUST 2, 2023

5) Lynparza (Olaparib) Lynparza is a PARP inhibitor , meaning it inhibits poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. The drug is indicated for the treatment of metastatic HER2- breast cancer with inherited BRCA1 or 2 mutations, ovarian cancer and fallopian tube cancer, among others. billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

FDA Law Blog

OCTOBER 24, 2024

Gibbs — A recent blog post focused on the potentially negative implications of the proposed Patent Eligibility Restoration Act (PERA) for manufacturers of generic drugs and biosimilar products. animal, viral, bacterial) DNA and RNA sequences. animal, viral, bacterial) DNA and RNA sequences.

Gene 64

Gene DNA Genetics Gene Sequencing 64

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. Unlike COVID-19 tests that need to be processed through PCR machines, the new rapid test is processed through a handheld DNA analyzer. Fujifilm Favipiravir (Avigan) Inhibits RNA-dependent RNA polymerase.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92